Sage Therapeutics (SAGE)
(Delayed Data from NSDQ)
$8.41 USD
+0.22 (2.69%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $8.40 -0.01 (-0.12%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 38% (96 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.95 | 1.59 | 9.99 |
Current Quarter Estimate | -1.56 | -1.21 | 61.00 |
Year Ago Quarter Estimate | -2.81 | -0.07 | 54.84 |
Next Quarter Estimate | -1.46 | -1.90 | 63.00 |
Next Year Estimate | -5.09 | 12.55 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 29.39 | 19.70 | 15.67 |
Next Year | 20.34 | 15.20 | 11.34 |
Last 5 Years | -457.20 | 7.00 | 8.10 |
Next 5 Years | 20.70 | 22.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -3.96 |
Price/Book (MRQ) | 0.82 | 1.54 |
Price/Cash Flow (MRFY) | NA | 8.95 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -458.30% | -61.35% |
Return on Equity (TTM) | -55.87% | -58.93% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.